RCM vs. TMX, MANT, PINC, FC, LH, DGX, DVA, CHE, CRVL, and AMED
Should you be buying R1 RCM stock or one of its competitors? The main competitors of R1 RCM include Terminix Global (TMX), ManTech International (MANT), Premier (PINC), Franklin Covey (FC), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), and Amedisys (AMED).
Terminix Global (NYSE:TMX) and R1 RCM (NASDAQ:RCM) are both mid-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, community ranking, profitability, analyst recommendations, risk, dividends and earnings.
92.2% of Terminix Global shares are owned by institutional investors. Comparatively, 61.1% of R1 RCM shares are owned by institutional investors. 2.3% of Terminix Global shares are owned by insiders. Comparatively, 36.8% of R1 RCM shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, R1 RCM had 4 more articles in the media than Terminix Global. MarketBeat recorded 4 mentions for R1 RCM and 0 mentions for Terminix Global. Terminix Global's average media sentiment score of 1.26 beat R1 RCM's score of 0.00 indicating that R1 RCM is being referred to more favorably in the news media.
R1 RCM received 216 more outperform votes than Terminix Global when rated by MarketBeat users. However, 61.32% of users gave Terminix Global an outperform vote while only 57.94% of users gave R1 RCM an outperform vote.
Terminix Global has higher earnings, but lower revenue than R1 RCM. R1 RCM is trading at a lower price-to-earnings ratio than Terminix Global, indicating that it is currently the more affordable of the two stocks.
R1 RCM has a consensus price target of $16.31, suggesting a potential upside of 27.11%. Given Terminix Global's higher probable upside, analysts clearly believe R1 RCM is more favorable than Terminix Global.
Terminix Global has a net margin of 3.15% compared to Terminix Global's net margin of -1.39%. R1 RCM's return on equity of 4.95% beat Terminix Global's return on equity.
Terminix Global has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Comparatively, R1 RCM has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500.
Summary
R1 RCM beats Terminix Global on 9 of the 17 factors compared between the two stocks.
Get R1 RCM News Delivered to You Automatically
Sign up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
